Chiesi and Aliada sign licence deal for enzyme replacement therapies
Aliada will receive upfront, sales-based payments, while Chiesi funds all development and commercialisation activities.
Analysis
View MoreSustainability vs suitability
Temperature-controlled packaging is under scrutiny as the pharmaceutical industry seeks to balance safety, efficiency and sustainability. In this evolving debate, Sarah Harris explores the challenges and opportunities, drawing on insights...
Integrating sustainability compliance
Bio shocks
Seal the deal
Excipient evolution shaping pharma innovation